IXICO plc (AIM:IXI)

Market Cap	10.19M
Revenue (ttm)	5.77M
Net Income (ttm)	-2.00M
Shares Out	92.67M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,314
Average Volume	33,276
Open	12.00
Previous Close	11.50
Day's Range	10.50 - 12.00
52-Week Range	6.35 - 13.00
Beta	0.68
RSI	28.58
Earnings Date	Dec 6, 2024

About IXICO

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 81
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: IXI

Financial Performance

In 2024, IXICO's revenue was 5.77 million, a decrease of -13.49% compared to the previous year's 6.67 million. Losses were -2.00 million, 69.9% more than in 2023.